NASDAQ:PRAX Praxis Precision Medicines Q4 2024 Earnings Results & Report $346.21 +8.62 (+2.55%) Closing price 04:00 PM EasternExtended Trading$346.17 -0.04 (-0.01%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Praxis Precision Medicines missed analyst earnings expectations but beat on revenue in its Q4 2024 results, released February 28, 2025. The company reported EPS of -$2.94 versus the -$2.76 consensus estimate, while revenue of $7.48 million topped the $362 thousand estimate by $7.12 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2024Report DateFebruary 28, 2025TimeBefore Market OpensConference Call9:30 AM ET Praxis Precision Medicines EPS ResultsActual EPS-$2.94Consensus EPS -$2.76Beat/MissMissed by -$0.18One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersPraxis Precision Medicines Revenue ResultsActual Revenue$7.48 millionExpected Revenue$362 thousandBeat/MissBeat by +$7.12 millionYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Annual Report (10-K)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Praxis Precision Medicines Q4 2024 Earnings FAQ Did Praxis Precision Medicines beat earnings estimates for Q4 2024? Praxis Precision Medicines (NASDAQ:PRAX) reported earnings of -$2.94 per share for Q4 2024, missing the consensus estimate of -$2.76. The report was announced on Friday, February 28, 2025. What was Praxis Precision Medicines' revenue for Q4 2024? Praxis Precision Medicines reported revenue of $7.48 million for Q4 2024, against a consensus estimate of $362 thousand. Praxis Precision Medicines Earnings HeadlinesPraxis Precision Medicines, Inc. (PRAX) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript2 hours ago | seekingalpha.comPraxis Precision Medicines (NASDAQ:PRAX) Earns Buy Rating from BTIG ResearchNovember 11 at 2:16 AM | americanbankingnews.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 11 at 1:00 AM | Behind the Markets (Ad)Praxis Precision Medicines (NASDAQ:PRAX) Shares Up 12.7% Following Better-Than-Expected EarningsNovember 11 at 1:41 AM | americanbankingnews.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock Has Average Price Target of $630.42 According to AnalystsNovember 10 at 2:29 AM | americanbankingnews.comPraxis Precision Medicines (PRAX) Stock Looks Rich Against Its Book ValueNovember 9 at 12:28 AM | finance.yahoo.comSee More Praxis Precision Medicines Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Praxis Precision Medicines? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Praxis Precision Medicines and other key companies, straight to your email. Email Address About Praxis Precision MedicinesPraxis Precision Medicines (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. The company applies neuroscience and precision-medicine research to conditions involving abnormalities in brain circuits and neuronal activity. Its investigational programs have included small-molecule therapies for disorders such as essential tremor and epilepsy, as well as genetic-medicine approaches for certain rare neurological conditions. These candidates are in development and are not approved treatments. Praxis is headquartered in Boston, Massachusetts, and is led by co-founder and Chief Executive Officer Marcio Souza.View Praxis Precision Medicines ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going AwayPowering Up the Moon: Redwire’s $40 Million NASA Award Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
